6-Bromo-5-nitroindirubin | 667463-74-3

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 吲哚及其衍生物
• 英文名称: 6-Bromo-5-nitroindirubin
• 英文别名: (3Z)-6-bromo-5-nitro-3-(3-oxo-1H-indol-2-ylidene)-1H-indol-2-one
• CAS: 667463-74-3
• 化学式: C₁₆H₈BrN₃O₄
• 分子量: 386.161
• InChiKey: MHUIZCQFERCVDT-YPKPFQOOSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  3.33
• 重原子数：
  24.0
• 可旋转键数：
  1.0
• 环数：
  4.0
• sp3杂化的碳原子比例：
  0.0
• 拓扑面积：
  101.34
• 氢给体数：
  2.0
• 氢受体数：
  5.0

反应信息

• 作为反应物：
  描述：

  6-Bromo-5-nitroindirubin 在 吡啶 、 盐酸羟胺 作用下， 反应 1.5h， 生成 6-Bromo-5-nitroindirubin-3'-oxime
  参考文献：
  名称：

  Structural Basis for the Synthesis of Indirubins as Potent and Selective Inhibitors of Glycogen Synthase Kinase-3 and Cyclin-Dependent Kinases

  摘要：

  Pharmacological inhibitors of glycogen synthase kinase-3 (GSK-3) and cyclin-dependent kinases have a promising potential for applications against several neurodegenerative diseases such as Alzheimer's disease. Indirubins, a family of bis-indoles isolated from various natural sources, are potent inhibitors of several kinases, including GSK-3. Using the cocrystal structures of various indirubins with GSK-3beta, CDK2 and CDK5/p25, we have modeled the binding of indirubins within the ATP-binding pocket of these kinases. This modeling approach provided some insight into the molecular basis of indirubins' action and selectivity and allowed us to forecast some improvements of this family of bis-indoles as kinase inhibitors. Predicted molecules, including 6-substituted and 5,6-disubstituted indirubins, were synthesized and evaluated as CDK and GSK-3 inhibitors. Control, kinase-inactive indirubins were obtained by introduction of a methyl substitution on N1.

  DOI：

  10.1021/jm031016d
• 作为产物：
  描述：

  N-(3-bromophenyl)-2-hydroxyiminacetamide 在 sodium nitrate 、 硫酸 、 sodium carbonate 作用下， 以 甲醇 为溶剂， 反应 4.25h， 生成 6-Bromo-5-nitroindirubin
  参考文献：
  名称：

  Structural Basis for the Synthesis of Indirubins as Potent and Selective Inhibitors of Glycogen Synthase Kinase-3 and Cyclin-Dependent Kinases

  摘要：

  Pharmacological inhibitors of glycogen synthase kinase-3 (GSK-3) and cyclin-dependent kinases have a promising potential for applications against several neurodegenerative diseases such as Alzheimer's disease. Indirubins, a family of bis-indoles isolated from various natural sources, are potent inhibitors of several kinases, including GSK-3. Using the cocrystal structures of various indirubins with GSK-3beta, CDK2 and CDK5/p25, we have modeled the binding of indirubins within the ATP-binding pocket of these kinases. This modeling approach provided some insight into the molecular basis of indirubins' action and selectivity and allowed us to forecast some improvements of this family of bis-indoles as kinase inhibitors. Predicted molecules, including 6-substituted and 5,6-disubstituted indirubins, were synthesized and evaluated as CDK and GSK-3 inhibitors. Control, kinase-inactive indirubins were obtained by introduction of a methyl substitution on N1.

  DOI：

  10.1021/jm031016d

文献信息

• Indirubin-Type Compounds, Compositions, and Methods for Their Use
  申请人：Meijer Laurent

  公开号：US20070276025A1

  公开（公告）日：2007-11-29

  Compounds and compositions including 6-bromo-indirubin, 5-amino-indirubin and N-methyl-indirubins and related indirubin derivatives are provided that are useful as selective modulators of glycogen synthase kinase-3, cyclin-dependent protein kinases or aryl hydrocarbon receptors. Methods of inhibiting or modulating cell growth or cell cycling are provided using the compounds of the invention. In other aspects, compounds and methods for the treatment of protozoan-mediated diseases, Alzheimer's disease and diabetes are provided.

  提供了包括6-溴吲哚红、5-氨基吲哚红和N-甲基吲哚红及相关吲哚红衍生物的化合物和组合物，它们可用作选择性调节糖原合酶激酶-3、周期蛋白依赖性蛋白激酶或芳香族羟基化酶的调节剂。使用本发明的化合物提供了抑制或调节细胞生长或细胞周期的方法。在其他方面，提供了治疗原虫介导疾病、阿尔茨海默病和糖尿病的化合物和方法。